Drew Armstrong
@ArmstrongDrew
Executive Editor, Endpoints News (@endpts).
Got a tip? DM me for my Signal handle.
ID:84684955
http://endpts.com 23-10-2009 20:47:08
7,9K Tweets
30,8K Followers
2,9K Following
Follow People
Nick Shipley, top lobbyist at I Am Biotech has left the group:
“It was clear that there were just some differences in policy and priorities that were emerging that led to a decision to move on in different directions.'
Exclusive from Jared Whitlock. endpts.com/top-lobbyist-a…
Scoop from Kyle LaHucik: Sanofi to close Dutch NK cell therapy biotech acquired in 2020 for $357M
endpts.com/exclusive-sano…
The numbers are in: digital health startups raised $2.7B in Q1, Rock Health reports
Ngai Yeung breaks down the first three months of the year here: endpts.com/health-tech-st…
a study almost 25 years in the making, as Ryan Cross the Science Boss explains in this exclusive story —
Rightway, a Tiger, Thrive and Khosla-backed PBM startup, raised $109M, according to a filing we spotted
Ngai Yeung has the scoop for Endpoints News endpts.com/exclusive-pbm-…
biotech’s megaround chart is starting to look like a CVS/Walgreens receipt 🧾
four more nine-figure financings for private biotechs this morning
$350M Metsera exclusive via Andrew Dunn
$132M Alterome and $160M Obsidian from Lei Lei Wu
and $128M Diagonal by me
Endpoints News